HOME › DRUGS › DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
ACTIVE SUBSTANCE / INN

DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

Brand name(s): DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
FDA LISTED
NONE (TENTATIVE APPROVAL)
NDA212527
ACTIVE SUBSTANCE
Dolutegravir Lamivudine Tenofovir Alafenamide
REGULATORS
FDA
SPONSORS / MAH
CIPLA USA INC.
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDENDA212527CIPLA USA INC.None (Tentative Approval)

FULL INTELLIGENCE ON DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →